Release date: 2009-07-14 On July 8th, researchers from Monash University in Australia made a groundbreaking discovery, revealing that obesity can activate the biological mechanisms behind type 2 diabetes. This breakthrough has opened new pathways for developing more effective treatments for this widespread condition. The study found that fat cells release a protein known as pigment epithelium-derived factor (PEDF), which interferes with the body's ability to respond to insulin. As a result, muscles and the liver become less sensitive to insulin, forcing the pancreas to produce more of it to maintain normal blood sugar levels. Over time, this increased demand can overwork the pancreas, potentially leading to its reduced function or even failure in producing insulin altogether. However, the research suggests that this process may be reversible. By blocking the action of PEDF, the body could regain insulin sensitivity, reducing the need for excessive insulin production and helping regulate blood sugar more effectively. Led by Dr. Matthew Watt, an associate professor of physiology at Monash University, the research was published in the latest issue of Cell-Metabolism, a respected scientific journal in the field of metabolism. Watt emphasized that these findings could significantly impact future diabetes treatment strategies, offering hope for the development of novel therapies targeting the root causes of type 2 diabetes. Type 2 diabetes is one of the most common forms of the disease, characterized by insulin resistance rather than a lack of insulin, as seen in type 1 diabetes. Gestational diabetes, on the other hand, occurs during pregnancy due to hormonal changes that affect insulin sensitivity. Understanding the mechanisms behind these conditions is crucial for improving patient outcomes and developing better management strategies. As scientists continue to explore the relationship between obesity and diabetes, this research marks an important step forward in the fight against one of the world's most pressing health challenges. With ongoing studies and clinical trials, the potential for innovative treatments grows stronger every day. We are a specialized manufacturers of Sexual Enhancement Materials from China; with advanced R & D and manufacturing in Enhance libido Materials . With high-quality products of Sex Enhance Ingredients , we can be a trust suppliers / factory. As a wholesale of Sexual Performance Imporve Material , we have the perfect after-sales service and technical support. Look forward to your cooperation! Sildenafil Citrate,Tongkat Ali Extract,Donkey-hide Glue Extract,Sex Enhance Ingredients,Sexual performance Imporve material Xi'an Quanao Biotech Co., Ltd. , https://www.quanaobio.com